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Hox11 is a homeobox gene essential for spleen formation in mice, since atrophy of the anlage of a developing
spleen occurs in early embryonic development in Hox11 null mice. HOX11 is also expressed in a subset of T-cell
acute leukemias after speciﬁc chromosomal translocations. Since the protein has a homeodomain and can
activate transcription, it probably exerts at least some of its effects in vivo by regulation of target genes.
Representational difference analysis has been used to isolate cDNA clones corresponding to mRNA species
activated following stable expression of HOX11 in NIH 3T3 cells. The gene encoding the retinoic acid-
synthesizing enzyme aldehyde dehydrogenase 1 (Aldh1), initially called Hdg-1, was found to be ectopically
activated by HOX11 in this system. Study of Aldh1 gene expression during spleen development showed that the
presence of Aldh1 mRNA inversely correlated with Hox11. Hox11 null mouse embryos have elevated Aldh1
mRNA in spleen primordia prior to atrophy, while Aldh1 seems to be repressed by Hox11 during organogenesis
of the spleens of wild-type mice. This result suggests that expression of Aldh1 protein is negatively regulated
by Hox11 and that abnormal expression of Aldh1 in Hox11 null mice may cause loss of splenic precursor cells
by aberrant retinoic acid metabolism.
The HOX11 protein is a member of the family of proteins
carrying a DNA-binding homeodomain. HOX11 was discov-
ered by its activation in a subset of T-cell acute leukemias with
t(10;14)(q24;q11) or t(7;10)(q35;q24) (6, 10, 18, 23). This ec-
topic expression is a contributary factor in the leukemogenesis
of those T-cell tumors with translocations affecting chromo-
some 10, band q24. While activation of HOX11 is a feature of
some T-cell tumors, the gene is normally not expressed in T
cells. In developing mouse embryos, Hox11 expression is re-
stricted to some parts of the brain, the developing branchial
arches, and the developing spleen (3, 35, 36). The last site of
expression seems particularly crucial in mouse development, as
creation of null mutations in Hox11 causes mice to be born
without spleens (36) as a result of atrophy of the spleen anlage
around embryonic days 13 to 14 (E13 to E14) (3).
The primary structure of the HOX11 protein suggested that
it may be a transcription factor, mainly because of the home-
odomain (4). Molecular experiments to dissect functional do-
mains of HOX11 conﬁrmed its ability to bind to speciﬁc DNA
sequences via the homeodomain (4, 43) and to activate tran-
scription (26, 50). The latter ability was due to the presence of
modular transcriptional activation domains (50), of which an
NH2-terminal module is needed for optimal transcription of a
chromosomal target gene (26). In addition, the ability of
HOX11 to interact with the catalytic subunits of protein phos-
phatases 1 and 2A has also been implicated in tumorigenesis
(26), but the signiﬁcance of this interaction for Hox11 function
in normal mouse embryogenesis is unclear.
Thus, both the expression of Hox11 during embryogenesis
(particularly in the developing spleen) and the ectopic expres-
sion of HOX11 following chromosomal translocation in T cells
may have varying consequences for the cell. These conse-
quences include activation and repression of gene expression
mediated by the homeodomain binding to DNA in a sequence-
speciﬁc manner and modulation of protein function via pro-
tein-protein interactions. The latter mode of action presum-
ably also has the effect of modulating gene expression
indirectly. In the light of these considerations, it was pertinent
to assess the effect on gene expression after ectopic activation
of HOX11 expression. As a model system, NIH 3T3 cells,
which stably express HOX11, were made, and mRNAs ex-
pressed as a result of this were cloned as cDNA fragments. In
this system, we have cloned and characterized two genes, class
1 aldehyde dehydrogenase (Aldh1) and Slim1. Aldh1 gene ex-
pression seems crucial for mouse spleen development since it
shows an inverse relationship to Hox11 expression in this de-
veloping organ.
MATERIALS AND METHODS
Cell lines. NIH 3T3 ﬁbroblasts stably expressing HOX11 or DH3-HOX11 (the
latter carries a deletion of the third helix of the HOX11 homeodomain) from the
pEF-BOS vector (28) have been previously described (26) and were grown in
Dulbecco modiﬁed Eagle medium supplemented with 10% fetal calf serum.
cDNA synthesis. Total cytoplasmic RNA was isolated from NIH 3T3 cell lines
by Nonidet P-40 lysis, phenol extraction, and ethanol precipitation. Polyadenyl-
ated [poly(A)
1] RNA was puriﬁed from total RNA by oligo(dT) cellulose chro-
matography. In preparing cDNA, we followed a protocol kindly supplied by
Hubank and Schatz (15). Poly(A)
1 RNA (5 mg) and oligo(dT)12–18 (2 mg) were
heated to 70°C for 10 min in a total volume of 20 ml and then incubated with 13
ﬁrst-strand buffer (Gibco BRL), 10 mM dithiothreitol, 0.5 mM each deoxynucle-
otide triphosphate, 20 U of RNasin (Promega), and 600 U of Superscript II
reverse transcriptase (Gibco BRL) in a total volume of 40 ml at 37°C for 1 h.
Second-strand synthesis was achieved by adding 40 mlo f5 3 second-strand
synthesis buffer [100 mM Tris-HCl (pH 7.5), 500 mM KCl, 25 mM MgCl2,5 0m M
(NH4)2SO4, 50 mM dithiothreitol, 0.25 mg of bovine serum albumin per ml], 2
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7030mlo f1 5m Mb-NAD,2Uo fEscherichia coli DNA ligase (New England Biolabs
[NEB]), 2.8 U of RNase H (Pharmacia), and 40 U of E. coli DNA polymerase I
(Boehringer Mannheim) in a ﬁnal volume of 200 ml and incubating the mixture
at 15°C for 2 h and then at 22°C for 1 h. Double-stranded cDNA was phenol-
chloroform extracted, ethanol precipitated in the presence of 2 mg of glycogen
carrier, and resuspended in 30 ml of 10 mM Tris-HCl (pH 7.5)–1 mM EDTA
(TE).
RDA oligonucleotides. Oligonucleotides used for representational difference
analysis (RDA) (15) were as follows: RBgl12, GATCTGCGGTGA; RBgl24,
AGCACTCTCCAGCCTCTCACCGCA; JBgl12, GATCTGTTCATG; JBgl24,
ACCGACGTCGACTATCCATGAACA; NBgl12, GATCTTCCCTCG; and
NBgl24, AGGCAACTGTGCTATCCGAGGGAA.
RDA. RDA was carried out as described previously (15). Double-stranded
cDNA (approximately 2 mg) was digested with DpnII (NEB), extracted with
phenol-chloroform, and ethanol precipitated. After resuspension, half of the
restricted cDNA was ligated to the RBgl12 (4 mg) and RBgl24 (8 mg) oligonu-
cleotides overnight at 16°C with 1,200 U of T4 DNA ligase (NEB) in a 60-ml
reaction mixture. Prior to addition of DNA ligase, the partially complementary
RBgl oligonucleotides were annealed by heating the ligation mixture to 50°C for
1 min and slowly cooling it to 10°C. The ligations were diluted to 200 ml with TE
and ampliﬁed by PCR with the RBgl24 oligonucleotide as the primer and5Uo f
Amplitaq (Perkin-Elmer Cetus) in a 200-ml volume. Twenty identical reaction
mixtures were prepared, with each receiving 2 ml of the diluted ligation mixture.
PCR samples were incubated at 72°C for 3 min to melt the RBgl12 oligomer
before addition of the polymerase. After a further 5 min at 72°C to ﬁll in the
ends, the samples were subjected to 20 cycles of PCR (95°C for 1 min and 72°C
for 3 min) and then combined, extracted with phenol-chloroform, precipitated
with isopropanol, and resuspended in 600 ml of water.
Driver DNA was prepared by digesting the cDNA representations (600 ml)
with DpnII, followed by phenol-chloroform extraction and isopropanol precipi-
tation. Tester DNA was prepared by gel purifying 1/10 of the driver DNA with
the Qiaex II system (Qiagen) and ligating it to the JBgl12 and JBgl24 adapters
as described above. The ﬁrst hybridization was performed by combining 0.4 mg
of the NIH 3T3 HOX11 tester DNA with 40 mg of NIH 3T3 driver DNA (a ratio
of 1:100). The mixture was ethanol precipitated and resuspended in 4 mlo fE E3
3 buffer, i.e., 30 mM N-(2-hydroxyethyl)piperazine-N-(3-propanesulfonic acid)
(pH 8.0)–3 mM EDTA, and covered with mineral oil. After heating the resus-
pension to 98°C for 5 min, 1 ml of 5 M NaCl was added and the solution was
incubated at 67°C for 20 h. Following hybridization, the mixture was diluted to
400 ml with TE along with 40 mg of yeast RNA as the carrier.
Ampliﬁcation of the reannealed tester was performed by adding 20 mlo ft h e
diluted hybridization mix to a 200-ml PCR mixture, with the JBgl24 oligonucle-
otide as the primer as described above. After 10 cycles of PCR, the reaction
mixtures were phenol-chloroform extracted, isopropanol precipitated, and resus-
pended in 40 mlo f0 . 2 3 TE. To remove single-stranded ampliﬁcation products,
half of the initial PCR products were incubated with 20 U of mung bean nuclease
in a 40-ml volume at 30°C for 35 min. The reaction was stopped by adding 160 ml
of 50 mM Tris-HCl (pH 8.9) and incubating the mixture at 98°C for 5 min. PCR
ampliﬁcation was continued by adding 20 ml of the mung bean nuclease-digested
products to a 200-ml PCR mixture as described above. After a further 18 cycles
of PCR, the products were extracted with phenol-chloroform, precipitated with
isopropanol, and resuspended in 100 ml of TE as the ﬁrst difference product
(DP1).
DP1s were digested with DpnII and ligated to new adapters (NBgl12 and -24),
and the RDA procedure was repeated as described above with tester-driver
ratios of approximately 1:800, 1:400,000, and 1:8,000,000 for the second, third,
and fourth rounds, respectively. J adapters were ligated to the tester for the third
round, and N adapters were ligated for the fourth round. At the end of the
procedure, DPs were cut with DpnII, gel puriﬁed, and cloned into the BamHI site
of pBluescript KS(1) (Stratagene). Transformed TG1 bacterial colonies were
screened by colony hybridization with the NIH 3T3 and NIH 3T3 HOX11 cDNA
representations as probes.
Filter hybridization analysis. Total RNA was isolated from cultured NIH 3T3
cells by Nonidet P-40 lysis. For Northern hybridizations, RNA samples (10 mg)
were denatured with glyoxal (50°C for 1 h), electrophoresed on 1.4% agarose
gels, and transferred to nylon membranes (45).
32P-labelled probes were pre-
pared by random priming (7), and the ﬁlters were hybridized in hybridization
buffer containing 33 SSC (13 SSC is 0.15 M NaCl plus 0.015 M sodium citrate),
103 Denhardt’s solution, 0.1% sodium dodecyl sulfate, and 250 mg of salmon
sperm DNA per ml at 65°C for 16 h (5). The ﬁlters were washed in 0.13
SSC–0.1% sodium dodecyl sulfate at 65°C and subjected to autoradiography at
270°C.
DNA ﬁlter hybridization (5, 41) was carried out essentially as described pre-
viously (21). The HOX11 probe used was a 1,025-bp coding region cDNA frag-
ment. The b-actin probe was a 500-bp cDNA fragment generated by reverse
transcription (RT)-PCR. The Slim1 (483 bp), Aldh1 (517 bp), and ATP synthase
(250 bp) probes were DpnII cDNA fragments obtained from the RDA proce-
dure. The T-cell receptor b chain (TCRb) probe was a 750-bp cDNA isolated
from pM131B10BB1 (39). The Hox2.9 probe was an 876-bp cDNA fragment.
Western blotting. Western blotting was carried out as described previously
with rabbit polyclonal antiserum raised against a bacterially expressed HOX11
protein (26).
In situ RNA hybridization. Cryosections (14 mm) of mouse embryos, either
from Hox11 homozygous mutant (2/2) (3) or wild-type (C57BL.6) embryos at
E12.5 and E13.5, were ﬁxed in 4% paraformaldehyde and pretreated with 0.25%
acetic anhydride in 0.1 M triethanolamine for 10 min. Hybridization was per-
formed overnight with probes 39 end labelled with
35S-dATP as previously de-
scribed (47, 48).
Antisense oligonucleotides used were as follows: for Hox11, GTGAACCTG
TCCTTTGTGTATCTGCGGTTACTCTCCATCC and AGTGTAGGCGCCT
CCAACCAAACAGCCAAGGCCATAGTCT, which correspond to mRNA po-
sitions 536 to 575 and 129 to 168, respectively; for Aldh1, ACAGCTAAGGGC
AGGGCCTATCTTCCAAATGAACATGAGC and CTGAGGGACAGAGCT
TAAGTCACAACTAGTCCTCCTCACC, which correspond to mRNA posi-
tions 519 to 558 and 1805 to 1844, respectively; for Aldh2, GGTTGCCAGGG
CTGGGCCCAGTTTCCATGCTTGCATCAGG and GCACATCTGGACGC
GTGATCGGTCTGCACTGAGCTTCATC, which correspond to mRNA posi-
tions 573 to 612 and 1742 to 1781, respectively; and for Tal1 (or Scl), CAACC
CAGGGGCCTAAAGGCCCCTGCCTGCTGGCCCTGGGCAGCC, which cor-
responds to mRNA positions 1000 to 1044. All numbering is relative to the start
site of the ATG initiation codon.
RESULTS
RDA cloning of HOX11-activated genes in NIH 3T3 cells.
Differential cDNA cloning methods, such as RDA (15, 22),
provide the means to compare different mRNA expression
proﬁles. We used cDNA RDA to compare levels of gene ex-
pression between NIH 3T3 cells and NIH 3T3 cells ectopically
expressing HOX11 (3T3-HOX11) following stable transfec-
tion. RDA was performed with NIH 3T3 or 3T3-HOX11
cDNA representations as either the driver or the tester (15).
Only when we used 3T3-HOX11 as the tester could consistent
bands be detected (by DP2) after agarose gel electrophoresis
(Fig. 1A, 3T3 HOX11 lanes DP2 to DP4), and one of these, a
267-bp band, hybridized strongly with a HOX11 probe (Fig.
1B). Thus, HOX11 was rapidly enriched by the RDA proce-
dure, reaching a maximal level by the DP3 round (Fig. 1B).
Conversely, hybridization with a b-actin probe showed deple-
tion of this sequence, which is common to the driver and tester,
from the DP3 and DP4 rounds of subtracted cDNA when
RDA subtraction was carried out with cDNA of either polarity
(Fig. 1B).
cDNA sequences enriched when 3T3-HOX11 cDNA was
used as the tester were identiﬁed by cloning gel-puriﬁed DPs,
followed by sequential hybridization with NIH 3T3 and 3T3-
HOX11 cDNA representations as probes. After we screened
264 recombinant colonies, we identiﬁed 126 differentially ex-
pressed clones, of which 77% represented HOX11. DNA se-
quencing revealed that the other clones fell into two main
groups. One group, 10% of the clones, corresponded to the
human and mouse SLIM1 and Slim1 genes, which encode a
novel LIM-only protein with four and a half LIM domains
(29), also called Kyo-T1 (44), and another group, 7% of the
clones, corresponded to the mouse Ahd-2 gene, which encodes
class 1 (cytosolic) aldehyde dehydrogenase (37). This gene was
provisionally called Hdg-1 when it was ﬁrst isolated (26).
The characteristics of enrichment of Slim1 and Aldh1 cDNAs
were assayed by hybridization of appropriate probes to ﬁlters
with aliquots of cDNA from each selected round (DP1 to DP4)
and either untransfected NIH 3T3 or the 3T3-HOX11 clone as
the tester mRNA population (Fig. 1B). This hybridization
analysis revealed that both Slim1 and Aldh1 cDNAs were en-
riched in the 3T3-HOX11 tester in a manner which paralleled
that of the HOX11 cDNA. The consistent ability of HOX11 to
stimulate both Slim1 and Aldh1 mRNA production was as-
sayed by Northern hybridization of RNAs from three different
NIH 3T3 clones stably transfected with the HOX11 expression
vector, two of which expressed HOX11 mRNA (Fig. 1C, clones
5 and 18) and one of which did not (Fig. 1C, clone 11). These
assays demonstrated that HOX11-positive clones 5 and 18
express both Slim1 and Aldh1 mRNAs but that untransfected
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However, in a wider analysis we observed that while Aldh1 was
always activated in HOX11-expressing NIH 3T3 clones, Slim1
was activated only in a proportion (about 50%; data not
shown). The reason for this difference is obscure at present but
may reﬂect clonal variation in responsiveness in the NIH 3T3
population, perhaps with respect to expression of a cofactor.
Nonetheless, the data indicate a clear relationship between
Aldh1 activation and HOX11 protein in this system.
ALDH1 expression in human lymphoid cell lines. The
HOX11 gene was ﬁrst discovered through its activation by the
chromosomal translocation t(10;14) or t(7;10) in some T-cell
acute leukemias. Possible effects of HOX11 expression on both
ALDH1 and SLIM1 mRNA levels in human lymphoid cell lines
were assayed by Northern ﬁlter hybridization (Fig. 2). Each
lane of RNA was assessed for integrity and loading by hybrid-
ization with an ATP synthase probe (Fig. 2, bottom section) and
with a TCRb or HOX11 probe for the T-cell lines. ALDH1
mRNA expression was surprisingly restricted and was detect-
able only in HEL cells (a cell line derived from a human
erythroleukemia) and a small cell lung carcinoma line
(LUDLU). Low levels of ALDH1 mRNA were found in
HepG2. It is noteworthy that none of the T-ALL lines (includ-
ing two derived from T-ALL tumors with translocations of
chromosome 10, band q24, involving the HOX11 gene) express
sufﬁcient ALDH1 mRNA to be detected in this Northern blot
assay. Conversely, SLIM1 mRNA was found in most of the
T-ALL lines (Fig. 2) as well as in one pre-B-ALL line
(ACVA-1) and a neuroblastoma line (N417). High levels of
SLIM1 mRNA were also found in the HepG2 liver cell line.
The expression of SLIM1 in these cancer cell lines is notewor-
thy, as previous studies of normal tissues have shown that
levels of expression of SLIM1, as judged by Northern blot
analysis, were high in skeletal and heart muscles but were
barely detectable in lymphoid tissues and completely absent in
liver (29, 30, 44).
Speciﬁcity of Aldh1 and Slim1 induction in 3T3-HOX11
cells. The speciﬁcity of Aldh1 gene activation was analyzed by
distinct transfection experiments involving NIH 3T3 cells ex-
pressing various HOX11 constructs as well as an unrelated Hox
gene, Hox2.9 (8, 31). First, the effect of inactivating the
HOX11 homeodomain was tested by stably transfecting NIH
3T3 cells with either a mutant of HOX11 lacking the third helix
of the homeodomain, DH3-HOX11 (26), complete HOX11, or
the vector only (Fig. 3A). RNAs were isolated from three
independent cell clones from each transfection, and Northern
blot analysis was carried out. While HOX11 mRNA was de-
tected in HOX11 and DH3-HOX11 transfected clones (but not
in the vector-only control clones) (Fig. 3A, BOS lanes), only
the HOX11 clones showed transcriptional activation of the
Aldh1 gene. Little or no Aldh1 mRNA was found in the mutant
HOX11 clones despite both Hox11 mRNA (Fig. 3A) and pro-
tein being detectable in the clones (in Fig. 3A, the bottom
FIG. 2. Expression of ALDH1 and SLIM1 mRNAs in T- and B-lymphoid cell lines. Results of Northern ﬁlter hybridization of total RNAs from the indicated cell
lines with Slim1, Aldh1, HOX11, TCRb, and ATP synthase probes are shown. RNAs were extracted from the T-cell lines (T) KOPT-K1, RPMI 8402, ALL-SIL, PER-255
(the last two carrying 10q24 translocations involving HOX11), SUP-T1, SUP-T13, CCRF-CEM (CEM), NALM, HBP-ALL, PER-117, and Jurkat or from the B-cell
lines. (B) 38B9, WEHI-231, RAJI, and ACVA-1. N417 is a neuroblastoma line; LUDLU is a small cell lung carcinoma line; HEL, K562, and 707 are erythroid lines,
and HepG2 is a hepatoma line.
FIG. 1. Enrichment of 3T3-HOX11 DPs by cDNA RDA. (A) Ethidium-stained agarose gel electrophoresis of starting cDNA DpnII fragment representations and
various RDA enriched populations obtained by mutual subtraction of NIH 3T3 cells (3T3) with 3T3-HOX11 (left lanes show products obtained with NIH 3T3 cells
as the tester and right lanes show products obtained with 3T3-HOX11 cells as the tester). Tester representation (R; unselected cDNA) and DP1, DP2, DP3, and DP4
are shown. The arrow indicates an enriched HOX11 DpnII fragment identiﬁed by Southern ﬁlter hybridization with a HOX11-speciﬁc probe. (B) Southern ﬁlter
hybridizations (with Slim1, Aldh1, HOX11, and b-actin probes as indicated) of the agarose gel-fractionated RDA DPs shown in panel A. Fragment sizes are indicated.
(C) Northern ﬁlter hybridization of 10 mg of total RNA prepared from untransfected NIH 3T3 cells and three independent 3T3-HOX11 clones and hybridized with
HOX11, Slim1, Aldh1, and ATP synthase probes (as indicated). 3T3-HOX11 clones 5 and 18 were found to express HOX11 protein, while clone 11 did not (data not
shown). Hybridization of the ﬁlter with ATP synthase was used to assess the quality of the RNA transferred.
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tiserum).
A similar dependence of Aldh1 induction on the ectopic
expression of HOX11 in NIH 3T3 cells was found when
HOX11 expression was controlled by the metallothionein
(MT) promoter. Proteins extracted from NIH 3T3 clones iso-
lated after transfection with the MT-HOX11 expression vector
or the vector only were analyzed by Western blotting with
anti-HOX11 antiserum following induction with zinc. A mod-
erate induction of HOX11 protein production was found in
this system (three- to fourfold) (Fig. 3B, lower section), and
HOX11 protein was found only in the MT-HOX11 clones. In
Northern (RNA) blot analysis, when the control ATP synthase
mRNA levels were compared to those of Aldh1, it was found
that Aldh1 gene expression is conﬁned to the MT-HOX11
clones. However, only a slight difference was seen in the Aldh1
levels in uninduced and induced cells (Fig. 3B, top section),
indicating that HOX11 protein levels in uninduced cells, due to
leakiness of the MT promoter, are sufﬁcient for its role in
activating Aldh1 expression in the NIH 3T3 cells.
The effect of the Hox2.9 protein (an unrelated homeodo-
main protein) (8, 31) on Aldh1 mRNA synthesis was analyzed
to assess the speciﬁcity of the HOX11 protein effect. NIH 3T3
clones were obtained following transfection with expression
vectors bearing genes coding for either HOX11 or Hox2.9, and
RNA was isolated. Figure 3C shows the results of Northern
hybridization analysis with two independent clones from each
transfection. Using an ATP synthase probe to control RNA
integrity, we conﬁrmed the presence of HOX11 or Hox2.9
mRNA in the appropriate clones. Aldh1 mRNA was found
only in the NIH 3T3 clones expressing HOX11 (Fig. 3C), con-
ﬁrming the speciﬁcity of HOX11 for Aldh1 mRNA induction.
The Aldh1 gene is repressed in the spleen primordium in the
presence of Hox11. During mouse embryogenesis, while Hox11
is expressed in a variety of locations (3, 35, 36), the sole defect
which can be observed in mice lacking functional Hox11 genes
is the absence of spleens at birth (3, 36). During early devel-
opment at around E12 to E13, mesoderm forms the develop-
ing-spleen anlage but the organ involutes and disappears by
the E14 stage in Hox11 null mice. The Hox11 null mutation,
however, does not affect viability or vigor in any other observ-
able way, and true breeding Hox11
2/2 mice can be obtained (3,
36). The genes which we have identiﬁed by ectopic expression
of HOX11 in NIH 3T3 cells may therefore play a role in spleen
development, and the absence of Hox11 protein in the null
mice might result in the absence of Aldh1 and/or Slim1. This
possibility was investigated by in situ RNA hybridization anal-
ysis of wild-type mouse embryos and Hox11 null mutant em-
bryos at E12.5 and E13.5.
This analysis failed to demonstrate any difference between
levels of Slim1 expression in the wild type and Hox11 null
embryos (data not shown). However, a surprising inverse re-
lationship was found between Hox11 and Aldh1 mRNA levels
in the developing spleen (Fig. 4). At E12.5 and E13.5 Hox11
mRNA can be observed in wild-type embryos in the developing
hindbrain and the spleen anlage (Fig. 4) whereas Aldh1 mRNA
is not detectable. As a control, the related mRNA for Aldh2
was analyzed and, unlike mRNA for Aldh1, showed wide-
spread expression. As the spleen anlage contains rather few
cells at E12.5, it may be possible to miss this developing organ
as the sagittal sections are made. Accordingly, we prepared
serial parasagittal sections of an E13.5 wild-type embryo and
hybridized one section with the Hox11 oligonucleotide, thereby
detecting the spleen anlage, the next section with the Aldh1
oligonucleotide, and the next with the Hox11 oligonucleotide
(Fig. 4, bottom section, left-hand embryo panels). Hox11
mRNA was detectable in both ﬂanking sections of the spleen
FIG. 3. Speciﬁcity of Aldh1 induction by ectopic expression of HOX11 RNA, extracted from NIH 3T3 cell clones stably transfected with various HOX11 or Hox2.9
expression constructs, was analyzed by Northern ﬁlter hybridization with Aldh1, HOX11, Hox2.9, and ATP synthase probe as indicated. (A) Induction of Aldh1 mRNA
by ectopic expression of HOX11 protein. RNAs were isolated from three independent NIH 3T3 clones stably transfected with either a HOX11 expression construct
(HOX11 controlled by the pEF-BOS expression cassette [HOX11]), a HOX11 expression construct encoding a mutant HOX11 protein lacking the third helix of the
homeodomain (DH3-HOX11), or the expression vector only (BOS). Aliquots were fractionated and transferred to nylon membranes prior to hybridization with an
Aldh1,aHOX11,o ra nATP synthase probe. Protein extracts were also prepared from these NIH 3T3 clones and analyzed by Western blotting. The presence of HOX11
protein was assayed (bottom section) with anti-HOX11 antiserum (26). (B) Stimulation of Aldh1 mRNA expression by HOX11 via the MT promoter. NIH 3T3 clones
expressing HOX11 were incubated in the presence or absence of 50 mM zinc for 36 h. RNAs were prepared, fractionated, and transferred to nylon membranes. These
were hybridized to Aldh1 and ATP synthase probes. Clone 1 is a control not expressing HOX11 protein (as shown by the Western blot developed with anti-HOX11
antiserum [bottom section]), and clone 2 is a HOX11-expressing line (see bottom section). (C) Aldh1 gene expression in response to HOX11 protein expression. We
obtained NIH 3T3 clones which were stably transfected with pEF-BOS-HOX11 or pEF-BOS-Hox2.9. Two clones were selected for their expression of HOX11 or Hox2.9
mRNA. RNA was prepared, electrophoresed, and transferred to nylon ﬁlters. These ﬁlters were hybridized with Aldh1, HOX11, Hox2.9, and ATP synthase probes as
indicated.
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ate section.
The data with wild-type mouse embryos show that Aldh1
mRNA expression is undetectable in the spleen anlage of
E13.5 embryos. We next examined in situ hybridization pat-
terns in parasagittal sections of E12.5 and E13.5 null Hox11
embryos. As previously shown (3, 36), Hox11 mRNA is unde-
tectable in Hox11 null embryos at stage E12.5, although a
transient spleen anlage does form (3). Aldh2, related to Aldh1,
is expressed in a broad spectrum of developing tissues of
Hox11 null embryos with a proﬁle which closely approximates
that of wild-type mice. However, unlike wild-type embryos,
Aldh1 mRNA expression was clearly detectable in the spleen
anlage in the Hox11 null embryos, suggesting negative regula-
tion of Aldh1 expression by Hox11 in embryogenesis, rather
than positive regulation as determined by the ectopic HOX11
expression in NIH 3T3 cells (Fig. 4). To conﬁrm the signiﬁ-
cance of this ﬁnding, an unrelated gene but one which is also
activated by chromosomal translocation in some human T-cell
acute leukemias, viz., Tal1/Scl (2), was examined in the Hox11
null embryos to assess whether altered Aldh1 mRNA levels
reﬂected a generalized alteration of gene expression. As with
Aldh2 expression, Tal1 mRNA levels at the E13.5 stage did not
vary between wild-type and Hox11 null embryos (Fig. 4), the
main sites of expression being the fetal liver and speciﬁc re-
gions of the hindbrain. We conclude, therefore, that the effects
observed in the Hox11 null embryos reﬂect a speciﬁc negative
regulatory role of Hox11 protein on the Aldh1 gene in mouse
spleen development.
DISCUSSION
HOX11 causes gene activation in NIH 3T3 cells. HOX11
appears to function as an important regulator of cell growth
and survival. Evidence for this comes from its normal role in
the development of splenic precursor cells as well as from its
tumorigenic role, implied by its association with the break-
points of chromosomal translocations in T-ALL and its ability
to immortalize murine hematopoietic progenitors in vitro (11,
12). HOX11 has been postulated to promote oncogenesis by
disrupting a G2/M checkpoint by binding to protein phospha-
tase 2A (17). However, it seems likely that HOX11 can also
function by activation or repression of genes crucial for cell
proliferation and/or differentiation in organogenesis of the
spleen.
We have used cDNA RDA (15, 22) to search for potential
target genes of HOX11, a T-cell oncogenic homeodomain
transcription factor. Using this technique, we have identiﬁed
Aldh1, a gene encoding an enzyme involved in retinoic acid
synthesis, as a gene which can be transcriptionally upregulated
by HOX11 in NIH 3T3 cells. Slim1, a novel LIM-only gene,
may also be a target for regulation by HOX11 in NIH 3T3 cells,
but factors other than simple intracellular expression of
HOX11 appear to be involved. SLIM1 belongs to a new family
of LIM proteins, which include SLIM2 and DRAL (9, 29, 44),
that contain four and a half LIM domains in which the N-
terminal domain consists only of the second half of the LIM
consensus. Two other LIM-only proteins have been identiﬁed
via their association with chromosomal translocations, viz.,
LMO1 and LMO2 (38). This ﬁnding suggests an interesting
possible link to HOX11, also activated by chromosomal trans-
locations in T-ALL, especially in view of the observed expres-
sion of SLIM1 mRNA in most T-ALL cell lines examined.
However, the possible signiﬁcance for development of T-ALL
will need to be addressed by functional studies, particularly
since not all the 3T3-HOX11 clones display Slim1 activation.
The activation of Aldh1 gene transcription following HOX11
FIG. 4. Aldh1 expression in embryonic mouse spleen is inversely correlated with Hox11. Wild-type (1/1) or Hox11 homozygous mutant (2/2) mouse embryos were
taken at E12.5 or E13.5, and parasagittal cryosections were hybridized in situ with oligonucleotide probes speciﬁc for Hox11, Aldh1, Aldh2,o rTal1/Scl mRNA. The
upper section shows E12.5 embryos. Consecutive sections of 1/1 or 2/2 embryos were hybridized with Hox11, Aldh1, and Aldh2 probes. The lower section shows E13.5
embryos. Consecutive sections of 1/1 or 2/2 embryos were hybridized with Hox11 and Aldh1 probes in the order shown. For comparison, we hybridized Tal1/Scl, which
showed its speciﬁc location within the hindbrain and fetal liver. Nissl-stained embryo sections are shown for comparison. SP, spleen; HB, hind brain; L, fetal liver.
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tested, and mutations of HOX11 which affect DNA binding
and transcriptional activation (26) affect Aldh1 expression. At
present it is not known whether this relationship is a direct
effect of HOX11 on the Aldh1 promoter. Although the HOX11
homeodomain is required for Aldh1 expression, it is possible
that HOX11 may bind to other intermediate genes whose
protein products themselves bind and activate the Aldh1 gene.
Alternatively, protein-protein interaction, which must be me-
diated through the homeodomain, may be responsible for the
molecular effect on Aldh1 gene transcription.
A possible Hox11-Aldh1 control system for developing
mouse spleen. In the activation experiments described in this
paper, we show that HOX11 ectopically expressed in NIH 3T3
cells results, directly or indirectly, in positive regulation of the
Aldh1 gene. Conversely, we present evidence that Aldh1 is
negatively regulated by Hox11 in the spleen anlagen of mouse
embryos. This paradox is possibly explained by the physiolog-
ical status of the Aldh1 gene in the two different situations.
There is evidence of other homeodomain transcription factors
that can act as both positive and negative regulators in differing
situations. Two notable examples are the Drosophila homeodo-
main proteins Antennapaedia and Ultrabithorax, which have
been shown to regulate the centrosomin gene. Antennapaedia
negatively regulates centrosomin in the visceral mesoderm and
positively regulates it in the central nervous system. For Ultra-
bithorax, the centrosomin regulatory role was found to be re-
versed in these tissues (13). A mechanism to account for these
observations has emerged from a recent study suggesting that
HOX protein interactions with cofactors such as PBX1 can
determine whether target gene activation or repression will
occur (34).
A major function of Aldh1 appears to be the biosynthesis of
retinoic acid by conversion of vitamin A (retinol) to its biolog-
ically active form, retinoic acid, a local regulator of cellular
proliferation, differentiation, and death. During retinoid sig-
nalling, retinol is converted to retinoic acid via two oxidative
reactions in target cells (19). The irreversible second step in
which retinoic acid is generated from retinal is catalyzed
mainly in the adult and exclusively in the early embryonic
mouse by NAD-dependent Aldh enzymes (27). The class 1 or
cytosolic form (Aldh1) and the closely related V1 and V2 or
Raldh-2 retinal dehydrogenases are the only Aldh isoenzymes
known to have this catalytic capacity (49, 51). It is noteworthy
that aldehyde oxidase, an enzyme which also has the capacity
to synthesize retinoic acid in vertebrates (32, 46), has recently
been proposed to be downstream of Drosophila homeoproteins
(20). Retinoic acid acts as a ligand for two families of nuclear
receptors, the retinoic acid and retinoid X receptors. This
diffusable morphogen is crucial to vertebrate embryogenesis,
where it is distributed in patterns that are highly regulated,
both temporally and spatially, by the localized expression of
retinoic acid-synthesizing enzymes, including Aldh1 (1, 25, 33).
As a developmental signal, retinoic acid is involved in numer-
ous processes ranging from anteroposterior patterning, both
along the main body axis and in developing limb buds, to
whole-organ formation. The need for vigilant control to be
maintained over retinoic acid biosynthesis is emphasized by the
highly teratogenic effect of a deﬁciency or excess of retinoic
acid during development (14, 40). Our results are compatible
with a role for Hox11 in regulating retinoic acid availability in
an organ-speciﬁc manner by suppressing Aldh1 expression in
the developing spleen. Aberrant expression of Aldh1 in spleen
primordia of Hox11 null mice provides a plausible molecular
mechanism to account for splenic involution, since it is known
that retinoids can regulate apoptosis. This has been demon-
strated in vitro as well as in whole organs in vivo (16, 24, 42).
Very little is known about the endogenous levels of retinoic
acid or its biosynthetic enzymes in the developing spleen; how-
ever, at least in the adult art, the spleen does not normally
demonstrate detectable retinoic acid-synthesizing activity (32).
Therefore, an aberrant increase in retinoic acid synthesis in the
spleen anlage at that particular stage of development may lead
to the observed asplenic phenotype of Hox11 null mutant mice.
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